ABANDONED – EXPRESS AFTER PUB
on 10 Jun 2022
Last Applicant/ Owned by
1111 Main Street
Vancouver
WA
98660
Serial Number
88751602 filed on 08th Jan 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
IMMUVANCE
therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host dis Read More
Classification Information
Class [005]
Pharmaceutical Products
therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
Class [042]
Computer & Software Services & Scientific Services
scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the foregoing excluding medical research and scientific research consulting services directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting
Class [044]
Medical, Beauty & Agricultural Services
providing a website featuring medical information; providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the forgoing excluding information directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting
Mark Details
Serial Number
No 88751602
Mark Type
No Service Mark
Attorney Docket Number
No 230042.204
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Jun 2022 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| 10th Jun 2022 | ABANDONMENT - AFTER PUBLICATION |
| 09th Jun 2022 | TEAS EXPRESS ABANDONMENT RECEIVED |
| 24th Mar 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Mar 2022 | SOU EXTENSION 3 GRANTED |
| 22nd Mar 2022 | SOU EXTENSION 3 FILED |
| 22nd Mar 2022 | TEAS EXTENSION RECEIVED |
| 14th Aug 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Aug 2021 | SOU EXTENSION 2 GRANTED |
| 12th Aug 2021 | SOU EXTENSION 2 FILED |